Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4 Aminobenzenearsonic Acid
2. 4-aminobenzenearsonic Acid
3. Acid, 4-aminobenzenearsonic
4. Acid, Arsanilic
5. Acid, P-aminophenylarsonic
6. Arsanilate, Sodium
7. Arsanilic Acid
8. Arsenilate, Sodium
9. Atoxyl
10. P Aminophenylarsonic Acid
11. P-aminophenylarsonic Acid
12. Sodium Arsenilate
1. Atoxyl
2. 127-85-5
3. Sodium Aminarsonate
4. Sodium Anilarsonate
5. Arsamin
6. Soamin
7. Sodium Hydrogen 4-aminophenylarsonate
8. Arsanilic Acid Sodium Salt
9. Sodium P-aminophenylarsonate
10. Monosodium (4-aminophenyl)arsonate
11. Sodium 4-aminophenylarsonate
12. 4-aminophenylarsonic Acid Sodium Salt
13. (4-aminophenyl)arsonic Acid Sodium Salt
14. Sodium;(4-aminophenyl)-hydroxyarsinate
15. Chebi:36049
16. Uc2409302q
17. 4-aminobenzenearsonic Acid Sodium Salt
18. Arsinosolvin
19. Nuarsol
20. Protoxyl
21. Trypoxyl
22. Sonate
23. Pro-gen Sodium
24. Sodium Arsonilate
25. Piglet Pro-gen V
26. Sodium P-arsanilate
27. Sodium Aniline-arsonate
28. Sodium-analine Arsonate
29. Sodium Aminophenylarsonate
30. Sodium Arsenilate
31. Anhydrous Sodium Arsanilate
32. Sodium Aminophenol Arsonate
33. Sodium P-aminobenzenearsonate
34. Ccris 4715
35. Hsdb 5189
36. Nci-c61176
37. Einecs 204-869-9
38. Nci-61176
39. Un2473
40. Ai3-29289-x
41. Natriumarsanilat
42. Unii-uc2409302q
43. Arsonic Acid, (4-aminophenyl)-, Monosodium Salt
44. Dsstox_cid_6022
45. Dsstox_rid_77986
46. Dsstox_gsid_26022
47. P-arsanilic Acid Sodium Salt
48. Sodium Arsanilate [mi]
49. Schembl1649934
50. Chembl3188525
51. Dtxsid2026022
52. Sodium Arsanilate [hsdb]
53. Sodium Arsanilate [mart.]
54. Sodium Arsanilate [who-dd]
55. Tox21_202893
56. Mfcd00067431
57. Sodium Hydrogen (4-aminophenyl)arsonate
58. Ncgc00260439-01
59. Sodium Arsanilate [un2473] [poison]
60. Cas-127-85-5
61. A0531
62. D88275
63. As-(4-aminophenyl)arsonic Acid Sodium Salt
64. Q2864363
65. 10361-33-8
| Molecular Weight | 239.04 g/mol |
|---|---|
| Molecular Formula | C6H7AsNNaO3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 238.953957 g/mol |
| Monoisotopic Mass | 238.953957 g/mol |
| Topological Polar Surface Area | 86.4 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 182 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
MEDICATION (VET): ALTHOUGH ONE OF THE MOST EFFECTIVE AGENTS FOR BLOODY ENTERITIS IN SWINE, ITS USE IS OFTEN ASSOCIATED WITH NUMEROUS RELAPSES AND STUNTING WHICH CAN LARGELY BE AVOIDED BY CONCURRENT USE AND FOLLOW UP USE OF BACITRACIN METHYLENE DISALICYLATE (QV). HERD BENEFITS SHOULD BE NOTICED WITHIN TWO-THREE DAYS.
Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 531
MEDICATION (VET): LITTLE BENEFIT HAS BEEN NOTED IN CATTLE TRIALS EXCEPT WITH SCOURING CALVES.
Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 531
MEDICATION (VET): HAS BEEN USED AS ANTHELMINTIC IN SWINE DYSENTERY & OTHER ENTERIC CONDITIONS OF PIGS & POULTRY
The Merck Index. 10th ed. Rahway, New Jersey: Merck Co., Inc., 1983., p. 1230
MEDICATION (VET): PROTOZOASTAT, GROWTH PROMOTER, ALTERATIVE
Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 530
MEDICATION (VET): GROWTH PROMOTION AGENT, ESP FOR SWINE & POULTRY; VET ANTIINFECTIVE, ESP FOR SWINE & POULTRY; CHEM INT FOR MELARSEN & CARBARSONE, ANTIPROTOZOAL DRUGS; ANTHELMINTIC & ANTISYPHILITIC FOR HUMANS (POSSIBLE USE)
SRI
SODIUM ARSANILATE WAS FORMERLY USED IN TREATMENT OF SYPHILIS AND TRYPANOSOMIASIS ... THERE HAVE BEEN AT LEAST 50 REPORTS IN THE LITERATURE ON DISTURBANCES OF VISION. BY 1932 SODIUM ARSANILATE WAS KNOWN TO HAVE CAUSED MORE THAN 80 CASES OF BLINDNESS AND WAS NO LONGER USED.
Grant, W.M. Toxicology of the Eye. 3rd ed. Springfield, IL: Charles C. Thomas Publisher, 1986., p. 114
VET: POISON. BE CERTAIN THAT NO OTHER FEED OR WATER SOURCE OF ARSENIC IS GIVEN AT THE SAME TIME. DO NOT FEED TO EGG LAYING BIRDS OR ADMINISTER TO DUCKS OR GEESE. AVOID CONTAMINATION WITH ANY OTHER LIVESTOCK OR HUMAN FEEDS.
Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 531
ATOXYL (100 MG/KG) ADMIN SC TO GUINEA PIGS WAS ELIMINATED MUCH MORE SLOWLY BY THE COCHLEAE THAN BY BLOOD & MUSCLE. ATOXYL WAS EXCRETED VIA KIDNEYS. BLOOD ATOXYL CONCN REACHED A MAXIMUM WITHIN 1/2 HR AFTER INJECTION & THEN DECREASED RAPIDLY.
ANNIKO M, PLANTIN LO; ARCH OTO-RHINO-LARYNGOL 215 (1): 81 (1977)
/Arsanilic/ acid and its sodium salt, both poorly absorbed from the digestive tract ... Sodium arsanilate may be absorbed through intact skin.
Gosselin, R.E., R.P. Smith, H.C. Hodge. Clinical Toxicology of Commercial Products. 5th ed. Baltimore: Williams and Wilkins, 1984., p. II-130
QUAL & QUANT ANALYSIS OF 24-HR URINE AFTER PARENTERAL ADMIN OF SODIUM P-ARSANILATE (15 MG ARSENIC/KG) TO RATS & GUINEA PIGS FAILED TO DETECT THE PRESENCE OF ANY ARSENIC-CONTAINING MATERIAL OTHER THAN UNCHANGED SODIUM P-ARSANILATE.
PMID:1147529 CRISTAU B ET AL; ANN PHARM FR 33 (1): 37 (1975)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Sodium Arsanilate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Arsanilate, including repackagers and relabelers. The FDA regulates Sodium Arsanilate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Arsanilate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium Arsanilate supplier is an individual or a company that provides Sodium Arsanilate active pharmaceutical ingredient (API) or Sodium Arsanilate finished formulations upon request. The Sodium Arsanilate suppliers may include Sodium Arsanilate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium Arsanilate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium Arsanilate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium Arsanilate active pharmaceutical ingredient (API) in detail. Different forms of Sodium Arsanilate DMFs exist exist since differing nations have different regulations, such as Sodium Arsanilate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium Arsanilate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium Arsanilate USDMF includes data on Sodium Arsanilate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium Arsanilate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium Arsanilate suppliers with USDMF on PharmaCompass.
Sodium Arsanilate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Arsanilate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Arsanilate GMP manufacturer or Sodium Arsanilate GMP API supplier for your needs.
A Sodium Arsanilate CoA (Certificate of Analysis) is a formal document that attests to Sodium Arsanilate's compliance with Sodium Arsanilate specifications and serves as a tool for batch-level quality control.
Sodium Arsanilate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Arsanilate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Arsanilate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Arsanilate EP), Sodium Arsanilate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Arsanilate USP).
LOOKING FOR A SUPPLIER?
